RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas-Fort Worth Area

RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas-Fort
Worth Area

IRVING, Texas, Nov. 9 /PRNewswire-FirstCall/ -- RBC Life Sciences, Inc. (OTC
Bulletin Board: RBCL), a provider of proprietary nutritional supplements and
wound care/pain management products, has been named one of the Top 100
workplaces in the Dallas-Fort Worth area.

Conducted by The Dallas Morning News, the Top 100 Places to Work 2009
competition surveyed more than 33,400 employees at hundreds of small, medium
and large firms throughout the DFW metropolitan area. The employees ranked
their companies on merits such as corporate leadership, compensation,
training, workplace flexibility and diversity.

RBC Life Sciences, which was ranked as the area's 57th best workplace, was one
of only 22 small companies to make the Top 100 Places to Work 2009.

"Employees are the life blood of any organization," said RBC Life Sciences
President and CEO, John W. Price. "It's humbling that our employees, even in
the midst of trying economic times that require workplace sacrifices, showed
they are satisfied."

About RBC Life Sciences

RBC Life Sciences develops, manufactures and markets quality nutritional
supplements and personal care products to a growing population of consumers
under the auspices of its networking marketing arm, RBC Life. Under its MPM
Medical brand, RBC Life Sciences also develops and markets to health care
professionals in the United States proprietary prescription and
nonprescription products for advanced wound care and pain management. All
products are tested for quality assurance in-house, and by outside independent
laboratories, to comply with regulations in the U.S. and in more than 30
countries in which the products are distributed. For more information, visit
the company's Web site at www.rbclifesciences.com.

The statements above, other than statements of historical fact, may be
forward-looking. Actual events will be dependent upon a number of factors and
risks including, but not limited to, changes in plans by the Company's
management, delays or problems in production, changes in the regulatory
process, changes in market trends, and a number of other factors and risks
described from time to time in the Company's filings with the Securities and
Exchange Commission.

SOURCE RBC Life Sciences, Inc.

Steve Brown, steve.brown@rbcls.com, or Ann Billings,
ann.billings@rbclifesciences.com, both of RBC Life Sciences, +1-972-893-4000